Marie Mclaughlin
People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function.
Mclaughlin, Marie; Sanal-Hayes, Nilihan E M; Hayes, Lawrence D; Berry, Ethan C; Sculthorpe, Nicholas F
Authors
Dr Nilihan Sanal-Hayes N.E.M.Sanal-Hayes@salford.ac.uk
Lecturer in Psychology
Lawrence D Hayes
Ethan C Berry
Nicholas F Sculthorpe
Abstract
This study aimed to compare flow-mediated dilation values between individuals with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and healthy age-matched controls to assess the potential implications for clinical management and long-term health outcomes. A case-case-control approach was employed, and flow-mediated dilation measurements were obtained from 51 participants (17 Long COVID patients, 17 ME/CFS patients, and 17 healthy age-matched controls). Flow-mediated dilation values were analysed using one-way ANOVA for between-group comparisons. Results revealed significantly impaired endothelial function in both Long COVID and ME/CFS groups compared to healthy age-matched controls as determined by maximum % brachial artery diameter post-occlusion compared to pre-occlusion resting diameter (6.99 ± 4.33% and 6.60 ± 3.48% vs. 11.30 ± 4.44%, respectively, both p < 0.05). Notably, there was no difference in flow-mediated dilation between Long COVID and ME/CFS groups (p = 0.949), despite significantly longer illness duration in the ME/CFS group (ME/CFS: 16 ± 11.15 years vs. Long COVID: 1.36 ± 0.51 years, p < 0.0001). The study demonstrates that both Long COVID and ME/CFS patients exhibit similarly impaired endothelial function, indicating potential vascular involvement in the pathogenesis of these post-viral illnesses. The significant reduction in flow-mediated dilation values suggests an increased cardiovascular risk in these populations, warranting careful monitoring and the development of targeted interventions to improve endothelial function and mitigate long-term health implications. [Abstract copyright: Copyright © 2023. Published by Elsevier Inc.]
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 28, 2023 |
Online Publication Date | Oct 11, 2023 |
Deposit Date | Oct 30, 2023 |
Publicly Available Date | Oct 30, 2023 |
Journal | The American Journal of Medicine |
Peer Reviewed | Peer Reviewed |
Pages | S0002-9343(23)00609-5 |
DOI | https://doi.org/10.1016/j.amjmed.2023.09.013 |
Keywords | Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Flow Mediated Dilation, Long-COVID |
Files
Accepted Version
(205 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Preproof Version
(893 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search